Sébastien B.
- Country
- France
- Department
- oncology
Research Overview
- A Phase III, Randomized, Open-label, Clinical Trial to Compare Pembrolizumab with Brentuximab Vedotin in Subjects with Relapsed or Refractory Classical Hodgkin Lymphoma
- Phase 3 Study of Zilovertamab Vedotin Plus R-CHP Versus R-CHOP in Untreated Diffuse Large B-Cell Lymphoma Patients
- Thromboprophylaxis in good and intermediate prognosis advanced germ cell tumors (GIG-T)
Data & Insights
Has run more than one trial at 8 of 100 partner sites.
Specializations
Oncological Focus
This investigator specializes in the study of advanced germ cell tumors, with particular attention to patients presenting good and intermediate prognosis stages.
- Metastatic germ cell cancer (GCT) management
- Risk stratification in advanced tumors
The research encompasses evaluation of patients with specific clinical characteristics including elevated baseline LDH and distinct anatomical presentations.
Thrombosis Prevention
The investigator focuses on thromboprophylaxis approaches in oncology patients, specifically studying prevention strategies for venous thromboembolic events.
- Thromboembolic risk assessment
- Preventive interventions in cancer patients
Their work examines risk factors and preventive measures in patients undergoing cisplatin-based chemotherapy treatments.
Treatment Optimization
The investigator's work centers on optimizing therapeutic approaches for cancer patients with specific risk factors.
- First-line chemotherapy protocols
- Patient-specific risk factor analysis
Their research considers multiple clinical parameters including body surface area and retroperitoneal lymph node involvement.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.